Worldwide Recombinant Cell Culture Supplements Market Insights (2019-2029): Focus on Product Type, Applications, Regional Data, Country Data, and Competitive LandscapeHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Worldwide Recombinant Cell Culture Supplements Market Insights (2019-2029): Focus on Product Type, Applications, Regional Data, Country Data, and Competitive LandscapeGlobeNewswireJanuary 3, 2020ReblogShareTweetShareDublin, Jan. 03, 2020 (GLOBE NEWSWIRE) -- The "Global Recombinant Cell Culture Supplements Market: Focus on Product Type, Applications, 5 Regional Data, 23 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2029" report has been added to ResearchAndMarkets.com's offering.The recombinant cell culture supplements market analysis projects the market to grow at a significant CAGR of 12.93% during the forecast period, 2019-2029. The recombinant cell culture supplements market generated $258.8 million in revenue in 2018, in terms of value.The recombinant cell culture supplements market growth has been primarily attributed to the major drivers in this market such as advantages offered by recombinant cell culture supplements and the promising impact displayed by them in culturing cells act as drivers for the growth of the market.Moreover, an increase in funding and investment supporting the advancement of life-science research with an ever-increasing demand for advanced cell culture systems have boosted the adoption rate of recombinant cell-culture supplements products.However, there are significant challenges that are restraining the market growth. These challenges include the shortage of skilled professionals and a lack of proper laboratory infrastructure. Further, the high cost of the cell culturing process and complications involved in it are also acting as a challenge for the market.Expert QuoteThe most important advantage of utilizing these recombinant proteins is that they facilitate large batch biomanufacturing with minimal risk of contamination and improved adhesion. Another advantage is that it involves animal-free manufacturing which in turn simplifies regulatory issues and export-import issues.Scope of the ReportThe recombinant cell culture supplements market report provides a holistic view of the market in terms of various factors influencing it, including product optimization, and technological advancements.The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the market. In addition, the study also includes exhaustive information on the unmet needs, perception of the new products, competitive landscape, market share of leading manufacturers, the growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global recombinant cell culture supplements market.Key Companies in the MarketThe key manufacturers who have been contributing significantly to the Recombinant Cell Culture Supplements Market include Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Hi-Media Laboratories, Sartorius AG, InVitro, SeraCare Life Sciences, Inc., GE Healthcare, Novozymes A/S, and Advanced Biotechnologies, Inc., among others.Key Topics CoveredExecutive Summary1 Scope of the Work1.1 Overview: Report Scope1.2 Segmentation of the Global Recombinant Cell Culture Supplements Market1.3 Assumptions and Limitations1.4 Key Questions Answered in the Report1.5 Base Year and Forecast Period2 Research Methodology2.1 Overview: Report Methodology3 Market Overview3.1 Fundamentals of Cell Culture3.2 Role of Media and Supplements3.3 Serum-free Media vs. Serum containing Media3.4 Technological Advancements of Defined Media and the Importance of Recombinant Cell Culture Supplements3.5 Recombinant Cell Culture Supplements Market Scenario3.6 Assumptions and Limitations for Market Size Calculations4 Market Dynamics4.1 Impact Analysis4.2 Market Drivers4.2.1 Benefits of Using Recombinant Cell Culture Supplements4.2.2 Increase in Funding and Investment in R&D of Life Science Sector4.2.3 Rising Demand for Advanced Cell Culture Products4.3 Market Restraints4.3.1 High Cost of Cell Biology Research4.3.2 Technical Considerations Associated with Cell Culture4.3.3 Lack of Infrastructure and Skilled Professionals for Cell-based Research4.4 Market Opportunities4.4.1 Rising Demand for Monoclonal Antibodies and Stem Cell Research4.4.2 Increasing Preference for Serum-Free Media5 Industry Insights5.1 Regulatory Scenario5.2 Patent Landscape6 Competitive Landscape6.1 Overview6.2 Key Developments and Strategies6.2.1 Product Launch and Development6.2.2 Collaborations, Partnerships, and Joint Ventures6.2.3 Acquisitions6.2.4 Business Expansions6.2.5 Others6.3 Market Share Analysis6.4 Growth Share Analysis7 Global Recombinant Cell Culture Supplements Market (by Products)7.1 Overview7.2 Recombinant Albumin (rAlbumin)7.3 Recombinant Insulin (rInsulin)7.4 Recombinant Epidermal Growth Factor (rEGF)7.5 Recombinant Transferrin (rTransferrin)7.6 Recombinant Trypsin (rTrypsin)7.7 Recombinant Insulin-like Growth Factor (rIGF)7.8 Recombinant Stem Cell Factor Protein (rSCF)7.9 Recombinant Aprotinin (rAprotinin)7.10 Recombinant Lysozyme (rLysozyme)7.11 Others8 Global Recombinant Cell Culture Supplements Market (by Application)8.1 Overview8.2 Stem Cell and Regenerative Medicine8.2.1 Stem Cell Therapy8.2.2 Cell Therapy8.2.3 Gene Therapy8.3 Bioproduction8.3.1 Monoclonal Antibodies8.3.2 Recombinant Proteins8.3.3 Vaccines8.3.4 Hormones8.3.5 Other Biological Products8.4 Academic and Research Application9 Global Recombinant Cell Culture Supplements Market (by Region)9.1 Overview9.2 North America9.3 Europe9.4 Asia-Pacific9.5 Latin America9.6 Rest-of-the-World10 Company Profiles10.1 Overview10.2 BBI Solutions10.3 Corning Incorporated10.4 Evercyte GmbH10.5 FUJIFILM Irvine Scientific10.6 Gemini Bio-Products10.7 HiMedia Laboratories10.8 InVitria10.9 Kingfisher Biotech, Inc.10.10 Lonza Group AG10.11 Merck KGaA10.12 PeproTech, Inc.10.13 Shenandoah Biotechnology10.14 Sino Biological Inc.10.15 STEMCELL Technologies Inc.10.16 Thermo Fisher Scientific Inc.Story continuesFor more information about this report visit https://www.researchandmarkets.com/r/n1kar0Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextHow investors are using ‘alternative’ data to track China’s recovery from coronaviruMarketWatchBank of Canada to stay put for now, but 2020 rate cut in play: Reuters pollReutersWorld stocks set for worst week since 2008 as virus fears grip marketsReutersOil-rich Alberta sees lower budget deficit in 2020-21, bets on recovery in crude pricesReutersRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceSomething 'dangerous' is happening beneath the surface of the market selloffYahoo Finance